2[2]Stet EH,De Abreu RA,Bokkerink JP,et al.Reversal of methyl-mercaptopurine ribonucleoside cytotoxity by purine ribonucleosides and adenine.Biochem Pharmacol,1995,49∶ 49- 56.
3[3]Krynetski KY,Evans WE.Pharmacogenetics as a melecular basis for individualized drug therapy:The thiopurine S-methyltransfe-rase paradigm.Pharm Res,1999,16∶ 342- 349.
4[4]Lennard L,Loon JA,Lilleyman JS,et al.Thiopurine pharmacogenetics in leukemia:Correlation of erythrocyte thiopurine methyltransferase activity and 6-thioguanine nucleotide concentrations.Clin Pharmacol Ther,1987,41∶ 18- 45.
5[5]Krynetski EY,Tai HL,Yates CR,et al.Genetic polymorphism of thiopurine S-methyltransferase:Clinical importance and molecular mechanisms. Pharmacogenetics, 1996,6∶ 279- 290.
6[6]Mcleod HL,Relling MV,Liu Q,et al.Polymorphic thiopurine methyltransferase in erythrocytes is indicative of activity in leu-kemic blasts from children with acute lymphoblastic leuke-mia.Blood,1995,85∶ 1897- 1902.
7[7]Krynetski EY,Schuetz JD,Galpin AJ,et al.A single point mutation leading to loss of catalytic activity in human thiopurine S-methyltransferase.Proc Natl Acad Sci USA,1995,92∶ 949- 953.
8[8]Tai HL,Krynetski EY,Schuetz EG,et al.Enhanced proteolysis of thiopurine S-methyltransferase(TPMT)encoded by mutant alleles in humans (TPMT 3A,TPMT 2):Mechanisms for the genetic polymorphism of TPMT activity. Proc Natl Acad Sci USA,1997,94∶ 6444- 6449.
9[9]dela Moureyre CSV,Debuysere H,Sabbagh N,et al.Detection of known and new mutations in the thiopurine S-methyltransferase gene by single-strand conformation polymorphism analysis.Hu-man Mutat,1998,12∶ 177- 185.
10[10]Yates CR,Krynetski EY,Loennechen T,et al.Molecular diagnosis of thiopurine S-methyltransferase deficiency:Genetic basis for azathioprine and mercaptopurine intolerance.Ann Intern Med,1997,126∶ 608- 616.
7Risch NJ.Searching for genetic determinants in the new millennium[J].Nature,2000,405(6788):847-856.
8Weinshilboum R.Inheritance and drug response[J].N Engl J Med,2003,348(6):529-537.
9Morganti M, Ciantelli M,Giglioni B,et al. Relationships between promoter polymorphisms in the thymidylate synthase gene and mRNA levels in colorectal cancers[ J ]. Eur J Cancer, 2005,41 (14) :2176-2183.
10Marcuello E, Ahes A, del Rio E,et al. Single nucleotide polymorphism in the 5 ' tandem repeat sequences of thymidylate synthase gene predicts for response to fluorouracil-based chemotherapy in advanced colorectal cancer patients [ J ]. Int J Cancer, 2004,112 (5) :733-737.
